Medtronic begins early feasibility study of the Intrepid transcatheter valve system - Cardiovascular News
INTREPID: The Transfemoral Option
New Therapies for Mitral Valve Regurgitation - Sentara
Transcatheter Mitral Valve Implantation with the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System | Future Cardiology
First Patient Treated in Pivotal Trial for Medtronic TMVR Valve | DAIC
Current Status of Transcatheter Tricuspid Valve Therapies – touchCARDIO
Structural Heart | Spectrum Health
Early Pilot Study Results Show Symptom Improvement With TMVR | tctmd.com
Medtronic Intrepid Transcatheter Mitral Valve Successfully Uses Transfemoral Delivery | DAIC
30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results | JACC: Cardiovascular Interventions
Frontiers | Current Devices in Mitral Valve Replacement and Their Potential Complications
Transcatheter Tricuspid Valve Replacement: A Feasible Solution to a Real-world Problem
Transcatheter Mitral Valve Replacement Therapies - American College of Cardiology
The Medtronic Intrepid: What's Coming - Michael Reardon, MD - YouTube
Intrepid prosthesis (Medtronic Inc.) | Download Scientific Diagram
Current transcatheter mitral valve replacement devices. A,... | Download Scientific Diagram
Developments in Transcatheter Mitral Valve Replacement | DAIC
Transcatheter Mitral Valve Replacement With a Novel Dual Stent Bioprosthesis | Circulation: Cardiovascular Interventions
The INTREPID Valve for Severe Tricuspid Regurgitation: First-in-Man Case Experience
30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results - ScienceDirect
Medtronic reports positive data on Intrepid TMVR system
Patient selection for trans-catheter mitral valve repair vs. replacement: ongoing indications and glimpse to the future
Transcatheter Mitral Valve Replacement with Dedicated Devices - Methodist DeBakey Cardiovascular J
